New drug tested for severe eczema relief
NCT ID NCT04643457
Summary
This study tested a new drug called UCB9741 to see if it is safe and if it can help control moderate-to-severe atopic dermatitis (eczema). First, healthy volunteers received single doses to check safety. Then, people with eczema received repeated doses to see if their skin condition improved. The main goals were to monitor side effects and measure how much the eczema cleared up.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Up0089 101
London, United Kingdom
-
Up0089 103
Manchester, United Kingdom
-
Up0089 104
Liverpool, United Kingdom
-
Up0089 201
Leiden, Netherlands
-
Up0089 301
Sofia, Bulgaria
-
Up0089 303
Pleven, Bulgaria
-
Up0089 304
Sofia, Bulgaria
-
Up0089 407
Berlin, Germany
-
Up0089 408
Heidelberg, Germany
-
Up0089 410
Leipzig, Germany
Conditions
Explore the condition pages connected to this study.